Extracellular vesicle delivery of myristoylated Cas9 highlights chromatin accessibility as an efficacy barrier in prostate cancer.

Molecular therapy : the journal of the American Society of Gene Therapy
Authors
Year of Publication
2025
Journal
Molecular therapy : the journal of the American Society of Gene Therapy
Date Published
12/2025
ISSN
1525-0024
DOI
10.1016/j.ymthe.2025.11.037
PubMed ID
41365293
Links